Placental growth factor: A predictive marker for preeclampsia?

Gynakologisch-geburtshilfliche Rundschau

Volumn 49, Issue 2, 2009, Pages 94-99

  Schmidt, Markus ^a   Dogan, Canan ^a   Birdir, Cahit ^a   Kuhn, Ulrich ^a   Gellhaus, Alexandra ^a   Kimmig, Rainer ^a   Kasimir Bauer, Sabine ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Angiogenesis; Placental growth factor; Preeclampsia, prediction

Indexed keywords

ACETYLSALICYLIC ACID; PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY OUTCOME; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 65249138298     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000197908     Document Type: Article

References (30)

1. Sibai BM, Dekker G, Kupferminc M: Preeclampsia. Lancet 2005; 365: 785-799.
2. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
3. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy: Report. Am J Obstet Gynecol 2002; 183: 1-22.
4. Sibai BM: Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102: 181-192.
5. Brown MA, Hague WM, Higgins J, Lowe S, McLowan L, Oats J, Peek MJ, Rowan JA, Walters BN: The detection, investigation and management of hypertension in pregnancy: executive summary. Aust NZ J Obstet Gynaecol 2000; 40: 133-138.
6. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW: Report of the Canadian Hypertension Society Consensus conference. 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997; 157: 715-725.
7. Dietl J: The pathogenesis of pre-eclampsia: new aspects. J Perinat Med 2000; 28: 464-471.
8. Oudejans CBM, Tjoa ML, Westerman BA, Mulders MAM, Van Wijk IJ, Van Vugt JMG: Circulating trophoblast in maternal blood. Prenat Diagn 2003; 23: 111-116.
9. Fisher SJ: The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol 2004; 2: 53-56.
10. Bdolah Y, Karumanchi SA, Sachs BP: Recent advances in understanding of preeclampsia. Croat Med J 2005; 46: 728-736.
11. Sane DC, Anton L, Brosnihan KB: Angiogenic growth factors and hypertension. Angiogenesis 2004; 7: 193-201.
12. Lam C, Lim KH, Karamunanchi SA: Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46: 1077-1085.
13. Gellhaus A, Schmidt M, Dunk C, Lye STJ, Kimmig R, Winterhager E: Decreased expression of angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol Hum Reprod 2006; 12: 389-399.
14. Schmidt M, Gellhaus A, Kasimir-Bauer S, Winterhager E, Kimmig R: Angiogenic factors during pregnancy: indicators of preeclampsia. Geburtsh Frauenheilkd 2007; 67: 228-235.
15. Stepan H, Faber R, Dornhöfer N, Huppertz B, Robitzki A, Walther T: New insights into the biology of preeclampsia. Biol Reprod 2006; 74: 772-776.
16. Schmidt M, Dogan C, Birdir C, Callies R, Kuhn U, Gellhaus A, Janetzko A, Kimmig R, Kasimir-Bauer S: Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor. Clin Chem Lab Med 2007; 45: 1504-1510.
17. Conde-Agudelo A, Villar J, Lindheimer M: World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 2004; 104: 1367-1391.
18. Duley L, Henderson-Smart DJ, Knight M, King JF: Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2004; 1: CD004659.
19. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of hypertensive disorder of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: 20-30.
20. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFLT-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
21. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
22. Bersinger NA, Odegard RA: Second and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83: 37-45.
23. Krauss T, Pauer HU, Augustin HG: Prospective analysis of placenta growth factor (PLGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004; 23: 101-111.
24. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK: Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101: 1266-1274.
25. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177-182.
26. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, Watanabe T, Kario K, Suzuki M: Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151-159.
27. Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E: Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset preeclampsia and intrauterine growth restriction.Ultrasound Obstet Gynecol 2008; 31: 301-309.
28. Simas TAM, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE: Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197: 244.e1-244.e8.
29. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R: Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-326.e13.
30. Stepan H, Unversucht A, Wessel N, Faber R: Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007; 49: 818-824.